Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3827 ARTÍCULOS , VIENDO DEL 3571 AL 3585

α-Synuclein elevation in human neurodegenerative diseases: experimental, pathogenetic, and therapeutic implications

Ulusoy A, Di Monte DA.

Mol Neurobiol. 2013 Apr;47(2):484-94. doi: 10.1007/s12035-012-8329-y. Epub 2012 Sep 4.

Using biomarkers to disentangle different causes of Parkinsonism

Aarsland D, Svenningsson P.

J Neurol Neurosurg Psychiatry. 2013 Feb;84(2):119. doi: 10.1136/jnnp-2012-303025. Epub 2012 Sep 4.

Werner coordination chemistry and neurodegeneration

Telpoukhovskaia MA, Orvig C.

Chem Soc Rev. 2013 Feb 21;42(4):1836-46. doi: 10.1039/c2cs35236b. Epub 2012 Sep 5.

Parkinson's disease subtypes: lost in translation?

Marras C, Lang A.

J Neurol Neurosurg Psychiatry. 2013 Apr;84(4):409-15. doi: 10.1136/jnnp-2012-303455. Epub 2012 Sep 5.

Treatment of patients with early and advanced Parkinson's disease with rotigotine transdermal system: age-relationship to safety and tolerability

Oertel W, LeWitt P, Giladi N, Ghys L, Grieger F, Boroojerdi B.

Parkinsonism Relat Disord. 2013 Jan;19(1):37-42. doi: 10.1016/j.parkreldis.2012.06.009. Epub 2012 Sep 3.

Mouse models of Parkinson's disease associated with mitochondrial dysfunction

Pickrell AM, Pinto M, Moraes CT.

Mol Cell Neurosci. 2013 Jul;55:87-94. doi: 10.1016/j.mcn.2012.08.002. Epub 2012 Aug 11.

The optic nerve: a "mito-window" on mitochondrial neurodegeneration

Maresca A, la Morgia C, Caporali L, Valentino ML, Carelli V.

Mol Cell Neurosci. 2013 Jul;55(100):62-76. doi: 10.1016/j.mcn.2012.08.004. Epub 2012 Aug 15.

Validity of the Nintendo Wii® balance board for the assessment of standing balance in Parkinson's disease

Holmes JD, Jenkins ME, Johnson AM, Hunt MA, Clark RA.

Clin Rehabil. 2013 Apr;27(4):361-6. doi: 10.1177/0269215512458684. Epub 2012 Sep 7.

Existing and emerging mitochondrial-targeting therapies for altering Parkinson's disease severity and progression

Pienaar IS, Chinnery PF.

Pharmacol Ther. 2013 Jan;137(1):1-21. doi: 10.1016/j.pharmthera.2012.08.010. Epub 2012 Aug 31.

Long-term efficacy and safety of safinamide as add-on therapy in early Parkinson's disease

Schapira AH, Stocchi F, Borgohain R, Onofrj M, Bhatt M, Lorenzana P, Lucini V, Giuliani R, Anand R; Study 017 Investigators.

Eur J Neurol. 2013 Feb;20(2):271-80. doi: 10.1111/j.1468-1331.2012.03840.x. Epub 2012 Sep 12.

Neural hijacking: action of high-frequency electrical stimulation on cortical circuits

Cheney PD, Griffin DM, Van Acker GM 3rd.

Neuroscientist. 2013 Oct;19(5):434-41. doi: 10.1177/1073858412458368. Epub 2012 Sep 10.

Juvenile Parkinsonism

Ware TL, Srinivasan J, Gonzalez L, Hardikar W, Scheinberg AM, Baker L, Prakash C, Ryan MM.

J Paediatr Child Health. 2013 May;49(5):409-11. doi: 10.1111/j.1440-1754.2012.02555.x. Epub 2012 Sep 13.

Clinical features and varieties of non-motor fluctuations in Parkinson's disease: a Japanese multicenter study

Seki M, Takahashi K, Uematsu D, Mihara B, Morita Y, Isozumi K, Ohta K, Muramatsu K, Shirai T, Nogawa S, Gotoh J, Yamaguchi K, Tomita Y, Yasutomi D, Nihei Y, Iwasawa S, Suzuki N.

Parkinsonism Relat Disord. 2013 Jan;19(1):104-8. doi: 10.1016/j.parkreldis.2012.08.004. Epub 2012 Sep 12.

Independent validation of the non motor symptoms scale for Parkinson's disease in Brazilian patients

Carod-Artal FJ, Martinez-Martin P.

Parkinsonism Relat Disord. 2013 Jan;19(1):115-9. doi: 10.1016/j.parkreldis.2012.08.008. Epub 2012 Sep 13.

Biomarkers of Parkinson's disease: current status and future perspectives

Wang J, Hoekstra JG, Zuo C, Cook TJ, Zhang J.

Drug Discov Today. 2013 Feb;18(3-4):155-62. doi: 10.1016/j.drudis.2012.09.001. Epub 2012 Sep 11.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias